Skip to content

mbeck

Pieter Cullis to receive Global Impact Award from Life Sciences BC

Dr. Pieter Cullis continues to accumulate accolades for his life’s work developing liposomal-based technologies as the basis for novel therapeutic approaches to diagnosing, treating, and curing disease. An additional recognition, “for his scientific entrepreneurialism and advancement of life sciences research,” is coming in the form of the Global Impact Award… Read More »Pieter Cullis to receive Global Impact Award from Life Sciences BC

NMIN start-up SeraGene wins Amgen-sponsored incubation support

The start-up company SeraGene, spun out of NMIN and co-founded by NMIN research co-leader Dr. Christian Kastrup (UBC), NMIN HQP Amy Wong-Strilchuk, and NMIN’s Founding Scientific Director, Dr. Pieter Cullis, has received a 2022 “Amgen Golden Ticket” at the UBC-based SBME Innovates incubation hub. UBC’s School of Biomedical Engineering (SBME)… Read More »NMIN start-up SeraGene wins Amgen-sponsored incubation support

Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize

For their contributions to the development of an mRNA-based COVID vaccine, NMIN’s Founding Scientific Director, Dr. Pieter Cullis (UBC), together with his colleagues Drs Katalin Karikó (University of Szeged) and Drew Weissman (University of Pennsylvania), have been jointly awarded the 2022 Tang Prize in in Biopharmaceutical Science. The prize recognizes… Read More »Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize

Canadian nanomedicines in the spotlight: Molecular Pharmaceutics

A new special issue of the American Chemical Society journal Molecular Pharmaceutics highlights outstanding work related to contemporary nanomedicine research in Canada. The issue, “Tiny Things, Huge Impact: Nanomedicine in Canada,”  was edited by NMIN researchers Dr. Shyh-Dar Li, Ellen Wasan, Marcel Bally, and Sarah Hedtrich, who contribute an editorial summarizing the… Read More »Canadian nanomedicines in the spotlight: Molecular Pharmaceutics

NMIN’s Founding Scientific Director receives Governor General’s Innovation Award

https://youtu.be/4eg6Y8x1JXE?list=PLh7NyssbO61nky9vVCrRsJG9izYAl5VV6Video profile of GGIA Laureate Acuitas A research team assembled in UBC approximately 40 years ago by NMIN’s Founding Scientific Director, Dr. Pieter Cullis, is receiving a 2022 Governor General’s Innovation Award for their work in developing lipid nanoparticle (LNP) systems to deliver cancer drugs to tumours and to enable… Read More »NMIN’s Founding Scientific Director receives Governor General’s Innovation Award

NMIN spin-off company NanoVation Therapeutics is expanding into UK

NMIN spin-off company NanoVation Therapeutics™ (NTx) is growing rapidly and is expanding its overseas operations with the launch of its first NanoVation GENErator™ in the UK, based at the Harwell Science and Innovation Campus near Oxford. The Honourable François-Philippe Champagne PC, MP (Minister of Innovation, Science and Industry) visits NanoVation’s… Read More »NMIN spin-off company NanoVation Therapeutics is expanding into UK

NMIN’s Founding Scientific Director wins 2022 Canada Gairdner International Award

Canadian nanomedicine scientist and NMIN founder Dr. Pieter Cullis, together with his Germany and US-based peers Drs Katalin Kariko and Drew Weissman, have been honoured with a 2022 Canada Gairdner International Award for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines. Dr. Cullis and colleagues at the… Read More »NMIN’s Founding Scientific Director wins 2022 Canada Gairdner International Award

Eight new recipients of NMIN’s Advanced Training Certification (ATC) announced

The NanoMedicines Innovation Network (NMIN) is pleased to announce eight new recipients of NMIN Advanced Training Certification (ATC). NMIN’s Advanced Training Certification, or ATC, recognizes an individual’s engagement in diverse capacity-building activities offered by NMIN, its partners, and other recognized organizations, where the learning involved goes “above and beyond” the… Read More »Eight new recipients of NMIN’s Advanced Training Certification (ATC) announced